Mårten Fernö
- Cancer Research top 0.2%
- Breast Cancer Treatment Studies 92
- Cancer Genomics and Diagnostics 34
- Oncology top 0.2%
- HER2/EGFR in Cancer Research 54
- Cancer Cells and Metastasis 30
- Cancer-related Molecular Pathways 15
- Pathology and Forensic Medicine top 0.5%
- Breast Lesions and Carcinomas 33
- Molecular Biology top 1%
- Gene expression and cancer classification 16
-
- Estrogen and related hormone effects 53
- Co-authors
- Åke BorgPär‐Ola BendahlBo BaldetorpHåkan OlssonLisa RydénKristina LövgrenD. KillanderMarkus Ringnér
- Journals
- New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)Nature Medicine (1 paper)
- Partner nations
- SwedenUnited StatesGermany
In The Last Decade
Mårten Fernö
230 papers receiving 9.8k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Cancer Research 4.1k
- Oncology 4.9k
- Pathology and Forensic Medicine 1.3k
- Molecular Biology 4.0k
- Pulmonary and Respiratory Medicine 1.9k
Countries citing papers authored by Mårten Fernö
This map shows the geographic impact of Mårten Fernö's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mårten Fernö with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mårten Fernö more than expected).
Fields of papers citing papers by Mårten Fernö
This network shows the impact of papers produced by Mårten Fernö. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mårten Fernö. The network helps show where Mårten Fernö may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mårten Fernö, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 21 | |
| 2 | 2021 | 4 | |
| 3 | 2019 | 12 | |
| 4 | 2017 | 10 | |
| 5 | 2015 | 22 | |
| 6 | 2015 | 36 | |
| 7 | 2014 | 2 | |
| 8 | 2013 | 35 | |
| 9 | 2013 | 47 | |
| 10 | 2013 | 24 | |
| 11 | A Molecular Taxonomy for Urothelial Carcinomabreakdown → | 2012 | 637 |
| 12 | 2010 | 58 | |
| 13 | 2009 | 23 | |
| 14 | 2007 | 154 | |
| 15 | 2007 | 28 | |
| 16 | 2004 | 25 | |
| 17 | 1997 | 17 | |
| 18 | HER-2/neu amplification predicts poor survival in node-positive breast cancer. | 1990 | 393 |
| 19 | Enzyme immunoassay of progesterone receptor in cancerous and normal endometrial tissue. A comparison with dextran coated charcoal method. | 1989 | 2 |
| 20 | Estrogen receptor activation in relation to previous estrogen treatment in carcinoma corporis uteri heterotransplanted into nude mice. | 1989 | 4 |
About Mårten Fernö
Mårten Fernö is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 232 papers that have together received 10.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (92 papers), HER2/EGFR in Cancer Research (54 papers), Estrogen and related hormone effects (53 papers), Cancer Genomics and Diagnostics (34 papers), Breast Lesions and Carcinomas (33 papers), Cancer Cells and Metastasis (30 papers), Gene expression and cancer classification (16 papers) and Cancer-related Molecular Pathways (15 papers). The work is most often cited by research in Cancer Research (4.1k citations), Oncology (4.9k citations) and Pathology and Forensic Medicine (1.3k citations). Mårten Fernö has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Åke Borg, Pär‐Ola Bendahl, Bo Baldetorp, Håkan Olsson, Lisa Rydén, Kristina Lövgren, D. Killander, Markus Ringnér, Helgi Sigurðsson and Lao H. Saal. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.